Reviva Pharmaceuticals Holdings Stock Forecast

Sell candidate since Jul 07, 2026 Loss -27.03%

The Reviva Pharmaceuticals Holdings, Inc. stock price gained 9.44% on the last trading day (Friday, 31st Jul 2026), rising from $0.400 to $0.438. During the last trading day the stock fluctuated 24.68% from a day low at $0.387 to a day high of $0.482. The price has fallen in 7 of the last 10 days and is down by -22.5% for this period. Volume fell on the last day by -12 thousand shares and in total, 11 thousand shares were bought and sold for approximately $4.74 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.32% during the next 3 months and, with a 90% probability hold a price between $0.196 and $0.574 at the end of this 3-month period.

RVPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 9.44%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Reviva Pharmaceuticals Holdings, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.447 and $0.576. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Reviva Pharmaceuticals Holdings, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.403 and $0.400. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Reviva Pharmaceuticals Holdings, Inc. finds support just below today's level at $0.403. If this is broken, then the next support from accumulated volume will be at $0.400 and $0.352.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0955 between high and low, or 24.68%. For the last week the stock has had daily average volatility of 23.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RVPH) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Reviva Pharmaceuticals Holdings, Inc. to open at $0.436, and during the day (based on 14 day Average True Range), to move between $0.396 and $0.480, which gives a possible trading interval of +/-$0.0840 (+/-21.23%) up or down from last closing price. If Reviva Pharmaceuticals Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 21.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.440 (0.49%) than the support at $0.403 (8.07%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Reviva Pharmaceuticals Holdings, Inc. stock A Buy?

Reviva Pharmaceuticals Holdings, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.370 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.436 ( 0.487%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk